Literature DB >> 7689190

Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma.

D A Kristt1, E Reedy, Y Yarden.   

Abstract

The purpose of this study was to determine if the expression of receptor tyrosine kinases would distinguish astrocytosis from astrocytoma. Because the expression of this family of receptor proteins is greater in higher-grade tumors, a graded series of both reactive and neoplastic astrocytic lesions in humans was evaluated. The reactive processes included both mild gliosis and severe (intense) gliosis. The two immunocytochemically detected membrane receptor proteins, p145 and p185, are those encoded by the kit and neu genes, respectively. Semi-quantitative assessments were made independently for the frequency and intensity of astrocytic immunostaining together with corollary immunocytochemical staining to detect glial fibrillary acidic protein. It was found that both mild gliosis and low-grade astrocytomas only minimally express these receptors. In contrast, severe gliosis and high-grade neoplasms consistently express these receptors at much higher levels. In both astrocytosis and astrocytomas, a cell with abundant perikaryal cytoplasm is most likely to be immunoreactive, often with dense reaction product concentrated at the periphery of the somal cytoplasm. The extent and pattern of immunoreactivity in high-grade astrocytomas preclude the interpretation that all immunoreactive cells were merely reactive astrocytes. We conclude that the expression of these receptors per se does not differentiate astrocytic neoplasia from reactive astrocytosis. Second, we conclude that immunocytochemically detectable levels of neu or kit receptor expression is not constitutive in normal astrocytes and in some stages of astrocytic neoplasia. On the basis of these findings, we speculate that some neoplastic astrocytes maintain and manifest the capacity to respond to transitory exogenous stimuli, as do reactive astrocytes. This reaction could include the elaboration of receptor tyrosine kinases. Alternatively, even if the function of these receptors in gliosis differs from that in gliomas, the common expression could still reflect an "active" state shared by astrocytes in these two processes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689190     DOI: 10.1227/00006123-199307000-00017

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  12 in total

1.  Neuregulin-1 enhances survival of human astrocytic glioma cells.

Authors:  Patricia S Ritch; Steven L Carroll; Harald Sontheimer
Journal:  Glia       Date:  2005-08-15       Impact factor: 7.452

Review 2.  Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas.

Authors:  A Besson; V W Yong
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

3.  CD117 expression in glial tumors.

Authors:  Neslihan Cetin; Gerald Dienel; Murat Gokden
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

Review 4.  The road less travelled: c-kit and stem cell factor.

Authors:  W Hamel; M Westphal
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

5.  Migration of fresh human malignant astrocytoma cells into hydrated gel wafers in vitro.

Authors:  J J Bernstein; W J Goldberg; E R Laws
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines.

Authors:  Fernanda B Morrone; Maria C Jacques-Silva; Ana P Horn; Andressa Bernardi; Gilberto Schwartsmann; Richard Rodnight; Guido Lenz
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

Review 7.  Trophic factors and central nervous system metastasis.

Authors:  G L Nicolson; D G Menter
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

8.  Phenotypic assays to identify agents that induce reactive gliosis: a counter-screen to prioritize compounds for preclinical animal studies.

Authors:  Samuel R Beckerman; Joaquin E Jimenez; Yan Shi; Hassan Al-Ali; John L Bixby; Vance P Lemmon
Journal:  Assay Drug Dev Technol       Date:  2015-07-31       Impact factor: 1.738

Review 9.  The role of trophic factors and autocrine/paracrine growth factors in brain metastasis.

Authors:  D G Menter; J L Herrmann; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

10.  The study of CD117 expression in glial tumors and its relationship with the tumor-type and grade.

Authors:  Parvin Mahzouni; Mohsen Jafari
Journal:  J Res Med Sci       Date:  2012-02       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.